Core Insights - Chainlink's native token (LINK) experienced a decline of approximately 1% after a strong start to the week, influenced by Grayscale's filing to convert its closed-end fund into an ETF [1] - Caliber, a real estate and asset manager, announced its first purchase of LINK tokens, initiating its digital asset treasury strategy, which led to a significant stock price increase of nearly 2,000% before a subsequent decline [2][3] Company Developments - Caliber became the first Nasdaq-listed firm to implement a treasury reserve policy focused on LINK, planning to accumulate tokens over time using credit lines, cash reserves, and equity-based securities [3] - The firm intends to stake the acquired tokens to generate yield, indicating a strategic long-term investment approach in digital assets [3] Trading Performance - LINK's trading performance showed a modest decline of 1% over a 24-hour period, with intraday price swings ranging from $22.84 to $24.46, reflecting volatility in the market [6] - Trading volume peaked at 3.78 million units, surpassing the 24-hour average, establishing support near the $23 price level [6] - The intraday high of $23.49 faced selling pressure, suggesting profit-taking activities and potential for further price declines [6]

Group 1 - Sharps Technology (NASDAQ: STSS) has completed a private financing round exceeding $400 million and plans to initiate a digital asset treasury strategy centered around SOL [1] - The total fundraising amount could reach $1 billion if all warrants are exercised [1] - The company has signed a non-binding agreement with the Solana Foundation to purchase $50 million of SOL at a 15% discount [1] Group 2 - Participating institutions in this financing round include Pantera, ParaFi, Monarq, and FalconX [1] - Sharps Technology will regularly disclose its SOL holdings while continuing to operate its medical device business [1]

Nasdaq-listed Caliber announces that its Board of Directors has formally approved the Digital Asset Treasury Strategy (DAT Strategy) and Digital Asset Treasury Policy (DAT Policy), planning to allocate a portion of its treasury funds to purchase LINK tokens from the Chainlink protocol for long-term appreciation and staking yield generation. https://t.co/bGGYSw7tt1 ...

Core Viewpoint - Caliber has approved a new digital asset treasury strategy focused on acquiring LINK tokens, positioning itself as a first-mover among U.S. public companies in blockchain-based treasury management practices [1][4] Group 1: Digital Asset Treasury Strategy - The Board of Directors has adopted a comprehensive digital asset treasury policy (DAT Policy) to manage and maximize returns from digital asset holdings, specifically LINK tokens [1][3] - The DAT Policy includes guidelines for acquisition, custody, management, security protocols, and internal controls [3][6] - The strategy aims to enhance shareholder value, strengthen the balance sheet, and improve liquidity [3][4] Group 2: Formation of Advisory Board - The Caliber Crypto Advisory Board (CCAB) has been established to provide guidance on the implementation and oversight of the DAT Strategy and related initiatives [2][5] - The CCAB will assist in aligning the company's capital structure with best practices in digital asset treasury strategies [2] Group 3: Investment Rationale - Holding LINK as a reserve asset is expected to provide exposure to a high-quality, liquid digital asset with long-term appreciation potential [4] - The integration of Chainlink's technology is anticipated to automate and improve key business processes, enhancing operational efficiency [4][5] - Recent partnerships between Chainlink and major institutions like Mastercard and SWIFT highlight its critical role in the future of finance [5] Group 4: Funding and Growth Strategy - Caliber plans to fund LINK acquisitions through existing cash reserves, equity-based securities, and its ELOC [6] - The company aims to leverage its 16-year track record of innovation in investment offerings to grow its LINK digital asset treasury [6][7]

RT MartyParty (@martypartymusic)New @solana DAT: Sharps Technology, Inc. Announces Over $400 Million Private Placement Seeking to Establish the Largest Solana Digital Asset Treasury StrategyNew York – August 25, 2025 – Sharps Technology, Inc. (the “Company” or “Sharps Technology”) (NASDAQ: “STSS” and “STSSW”) today announced the pricing of a private placement offering to support its plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of th ...

Core Points - ETHZilla Corporation has authorized a stock repurchase program of up to $250 million of its outstanding shares, effective immediately [1][6] - The company holds a total of 102,237 Ether (ETH) at an average acquisition price of $3,948.72, valued at approximately $489 million [1][7] - In addition to ETH, ETHZilla has approximately $215 million in USD cash equivalents [1][7] Company Strategy - The company is focused on deploying capital to accelerate its Ethereum treasury strategy and aims to maximize shareholder value through the stock repurchase program [2] - ETHZilla's treasury strategy includes a partnership with Electric Capital to pursue differentiated yield generation opportunities that aim to outperform traditional ETH staking [12] - The company is evolving from a biotechnology focus to include software-enabled gaming and entertainment, while continuing to develop its ETH treasury strategy [13] Financial Metrics - As of August 24, 2025, ETHZilla's total ETH and ETH equivalents held is 102,237, valued at approximately $489 million [7] - The company has issued 3.3 million shares through at-the-market offerings, raising net proceeds of approximately $20.9 million [4] - The average purchase price of ETH has increased from $3,807 to $3,949 over the past few weeks [4]

Core Viewpoint - Sharps Technology, Inc. is implementing a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, to leverage its high transaction throughput and yield generation capabilities [1][18]. Company Overview - Sharps Technology is a medical device and pharmaceutical packaging company that offers patented smart-safety syringe products, focusing on ultra-low waste capabilities and specialized copolymer technology for pre-fillable syringes [17]. Digital Asset Strategy - The company has announced a private placement offering of over $400 million to support its digital asset treasury strategy, with a primary focus on acquiring SOL [6][9]. - The offering includes common stock and stapled warrants at a purchase price of $6.50 per unit, with warrants exercisable for three years at an exercise price of $9.75 [6][8]. - The net proceeds from the offering will be used to fund the acquisition of SOL, establish treasury operations, and for general corporate purposes [9]. Solana Blockchain Insights - Solana is recognized as the fastest and most used public blockchain, processing more transactions and generating more on-chain fee revenue than all other blockchains combined [1][5]. - The blockchain offers approximately 7% staking yields, the highest among the top five major blockchains, and has generated $1.3 billion in revenue for apps year-to-date [4][7]. - Solana supports over 7,500 new developers in 2024, making it the fastest-growing blockchain ecosystem by developer count [7]. Leadership and Advisory Team - Alice Zhang has been appointed as the Chief Investment Officer, bringing experience from her previous role at Jambo, and will lead the digital asset treasury strategy [2][10]. - James Zhang, co-founder of Jambo, will serve as a strategic advisor, collaborating with top-tier asset managers to grow the digital asset treasury [3][11]. Institutional Support - The global adoption of Solana's ecosystem is accelerating, with increasing institutional support for its vision of a unified market for tradeable assets [2]. - The company has signed a non-binding letter of intent with the Solana Foundation to purchase $50 million of SOL at a 15% discount, contingent on certain conditions [9].

Core Viewpoint - Cosmos Health Inc. has initiated the purchase of Ethereum (ETH) as part of its digital asset treasury reserve strategy, marking a significant step towards integrating cryptocurrency into its financial strategy [1][2]. Group 1: Company Strategy - The company has completed an initial purchase of $1 million in ETH, utilizing a financing facility of up to $300 million with a U.S.-based institutional investor [1]. - CEO Greg Siokas expressed enthusiasm about building an ETH treasury, indicating a shift from holding only cash to incorporating assets with strong appreciation potential [2]. - The strategic move is supported by the growing adoption of ETH by institutional investors, its inclusion in ETFs, and the proposed expansion of cryptocurrency access in retirement plans [2]. Group 2: Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada [3]. - The company owns a portfolio of proprietary pharmaceutical and nutraceutical brands and operates under European Good Manufacturing Practices (GMP) [3]. - Cosmos Health is expanding its global distribution platform and has established R&D partnerships targeting major health disorders, enhanced by AI drug repurposing technologies [3].

Core Viewpoint - 180 Life Sciences Corp. (d/b/a ETHZilla) is focusing on increasing its Ethereum (ETH) holdings through a recent $156 million convertible notes offering, which is part of its broader ETH treasury strategy [1][2][6] Group 1: Financing and Strategy - The company has closed a $425 million private placement and subsequently sold approximately $156 million in senior secured convertible notes due 2028 [1][2] - Proceeds from the convertible notes will primarily be used to purchase more ETH and support the company's ETH treasury strategy [2][3] - The convertible notes will not accrue interest for the first six months and will have a 4% annual interest rate thereafter, maturing three years from the issuance date [2] Group 2: Company Operations and Future Plans - The company aims to rebrand as ETHZilla Corporation and establish itself as a leader in on-chain treasury management among public companies [6] - A significant portion of the company's operations will focus on becoming an ETH accumulation vehicle, designed to provide community access to the Ethereum network [7] - The company plans to implement a differentiated yield generation program in partnership with Electric Capital, aiming to outperform traditional ETH staking [7] Group 3: Legal and Advisory Support - Clear Street LLC acted as the financial advisor and exclusive placement agent for the convertible notes offering, while The Loev Law Firm, PC and Reed Smith LLP provided legal advice to the company [4]

Core Insights - Artelo Biosciences, Inc. has entered into a securities purchase agreement for a PIPE, raising approximately $9.475 million through the sale of 906,687 shares of common stock and associated warrants [1][5] - The company plans to utilize the proceeds to launch a Solana-centric digital asset treasury strategy, marking it as the first publicly traded pharmaceutical company to adopt Solana's native cryptocurrency, SOL, as a reserve asset [2][13] - Bartosz Lipiński, a key figure in the Solana ecosystem, will serve as a technical partner for Artelo's treasury initiative, emphasizing the strategic importance of this move for the company's growth [3][4] Financial Strategy - The funds raised will support Artelo's ongoing business and its innovative treasury initiative, which aims to diversify its balance sheet and enhance liquidity management [2][5] - The treasury strategy is designed to preserve working capital for the continued development of Artelo's proprietary therapeutics while providing exposure to a next-generation monetary network [13] Market Positioning - Artelo's adoption of SOL positions the company at the intersection of biotechnology and decentralized finance, showcasing its commitment to forward-thinking financial management [2][4] - The integration of SOL into Artelo's treasury strategy is expected to enhance shareholder value and demonstrate leadership in the evolving capital landscape of the biotech sector [5][13] Solana Overview - Solana, launched in 2020, is recognized for its high-performance blockchain capabilities, processing over 35.99 million daily transactions and boasting a Total Value Locked (TVL) of $89.417 billion, surpassing Ethereum [11][10] - The network's scalability and decentralized infrastructure are highlighted as key advantages, making it a cornerstone of the future financial ecosystem [4][10]